Importance of the Graded Chronic Pain Scale as a Biopsychosocial Screening Instrument in TMD Pain Patient Subtyping

Aims: To compare the suitability of Graded Chronic Pain Scale (GCPS) pain intensity and interference assessments (GCPS version 1.0 vs 2.0) for the biopsychosocial screening and subtyping of Finnish tertiary care referral patients with TMD pain. Methods: Altogether, 197 TMD pain patients participated in this study. All patients received Axis II specialist-level psychosocial questionnaires from the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD-FIN) and Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD-FIN), as well as questionnaires for the assessment of additional pain-related, biopsychosocial, and treatment-related variables. Clinical examinations were performed according to the DC/TMD Axis I protocol. The patients were categorized into TMD subtypes 1, 2, and 3 (GCPS I and II-low; II-high; and III and IV, respectively) based on their biopsychosocial profiles according to GCPS versions 1.0 and 2.0. Results: The distribution of TMD pain patients into TMD subtypes was similar according to the GCPS 1.0 compared to the GCPS 2.0. Over 50% of the patients were moderately (TMD subtype 2) or severely (TMD subtype 3) compromised. Patients in subtype 3 experienced biopsychosocial symptoms and reported previous health care visits significantly more often than patients in subtypes 1 and 2. Patients in subtype 2 reported intermediate biopsychosocial burden compared to subtypes 1 and 3. Conclusion: TMD pain patients differ in their biopsychosocial profiles, and, similarly to the GCPS 1.0, the GCPS 2.0 is a suitable instrument for categorizing TMD tertiary care pain patients into three biopsychosocially relevant TMD subtypes. The GCPS 2.0 can be regarded as a suitable initial screening tool for adjunct personalized or comprehensive multidisciplinary assessment.

DC/TMD; GCPS; psychosocial; RDC/TMD; temporomandibular disorders

1. Signs and symptoms of temporomandibular disorders. In: Okeson J (ed). Management of Temporomandibular Disorders and Occlusion, ed 8. St Louis, MI: Elsevier, 2020:132–173.

2. Maixner W, Diatchenko L, Dubner R, et al. Orofacial pain prospective evaluation and risk assessment study – the OPPERA Study. J Pain 2011;12:T4–T11.e2.

3. Bair E, Gaynor S, Slade GD, et al. Identification of clusters of individuals relevant to temporomandibular disorders and other chronic pain conditions: The OPPERA study. Pain 2016;157:1266–1278.

4. Slade GD, Bair E, Greenspan J, et al. Signs and symptoms of first-onset TMD and sociodemographic predictors of its development: The OPPERA prospective cohort study. J Pain 2013;14(suppl):T20–T32.e1-3.

5. Ohrbach R, Eric B, Fillingim RB, et al. Clinical orofacial characteristics associated with risk of first-onset TMD: The OPPERA prospective cohort study. J Pain 2013;14(suppl):T33–T50.

6. Fillingim RB, Ohrbach R, Greenspan JD, et al. Psychological factors associated with development of TMD: The OPPERA prospective cohort study. J Pain 2013;14(suppl 12):T75–T90.

7. Sanders AE, Slade GD, Bair E, et al. General health sta-tus and incidence of first-onset temporomandibular disorder: The OPPERA prospective cohort study. J Orofac Pain 2013;14:51–62.

8. Slade GD, Sanders A, Bair E, et al. Preclinical episodes of orofacial pain symptoms and their association with healthcare behaviors in the OPPERA prospective cohort study. Pain 2013;154:750–760.

9. Slade GD, Diatchenko L, Bhalang K, et al. Influence of psychological factors on risk of temporomandibular disorders. J Dent Res 2007;86:1120–1125.

10. Dworkin SF, Turner JA, Mancl L, et al. A randomized clinical trial of a tailored comprehensive care treatment program for temporomandibular disorders. J Orofac Pain 2002;16:259–276.

11. Suvinen TI, Reade PC, Kemppainen P, Könönen M, Dworkin SF. Review of aetiological concepts of temporomandibular pain disorders: Towards a biopsychosocial model for integra-tion of physical disorder factors with psychological and psychosocial illness impact factors. Eur J Pain 2005;9:613–633.

12. Manfredini D, Winocur E, Ahlberg J, Guarda-Nardini L, Lobbezoo F. Psychosocial impairment in temporomandibular disorders patients. RDC/TMD axis II findings from a multi-centre study. J Dent 2010;38:765–772.

13. Ohrbach R, Dworkin SF. Five-year outcomes in TMD: Relationship of changes in pain to changes in physical and psychological variables. Pain 1998;74:315–326.

14. Suvinen TI, Kemppainen P, Le Bell Y, Valjakka A, Vahlberg T, Forssell H. Research Diagnostic Criteria Axis II in screening and as a part of biopsychosocial subtyping of Finnish patients with temporomandibular disorder pain. J Orofac Pain 2013;27:314–324.

15. Maixner W, Fillingim RB, Williams DA, Smith SB, Slade GD. Overlapping chronic pain conditions: Implications for diagnosis and classification. J Pain 2016;17(suppl 9):T93–T107.

16. Smith MT, Wickwire EM, Grace EG, et al. Sleep disorders and their association with laboratory pain sensitivity in temporomandibular joint disorder. Sleep 2009;32:779–790.

17. Fillingim RB, Slade GD, Greenspan JD, et al. Long-term changes in biopsychosocial characteristics related to temporomandibular disorder: Findings from the OPPERA study. Pain 2018;159:2403–2413.

18. Von Korff M, Dunn KM. Chronic pain reconsidered. Pain 2008;138:267–276.

19. Turk DC, Rudy TE. Toward an empirically derived taxonomy of chronic pain patients: Integration of psychological assessment data. J Consult Clin Psychol 1988;56:233–238.

20. Dworkin SF, Huggins KH, Wilson L, et al. A randomized clinical trial using research diagnostic criteria for temporomandibular disorders-axis II to target clinic cases for a tailored self-care TMD treatment program. J Orofac Pain 2002;16:48–63.

21. Dworkin SF, LeResche L. Research diagnostic criteria for temporomandibular disorders: Review, criteria, examinations and specifications, critique. J Craniomandib Disord 1992;6:301–355.

22. Von Korff M, Dworkin SF, Le Resche L. Graded chronic pain status: An epidemiologic evaluation. Pain 1990;40:279–291.

23. Von Korff M, Ormel J, Keefe FJ, Dworkin SF. Grading the se-verity of chronic pain. Pain 1992;50:133–149.

24. Ozdemir-Karatas M, Peker K, Balık A, Uysal O, Tuncer EB. Identifying potential predictors of painrelated disability in Turkish patients with chronic temporomandibular disorder pain. J Headache Pain 2013;14:17.

25. Manfredini D, Facero L, Gregorini G, Cocilovo F, Guarda-Nardini L. Natural course of temporomandibular disorders with low pain-related impairment: A 2-to-3-year follow-up study. J Oral Rehabil 2013;40:436–442.

26. Dworkin SF, Sherman J, Mancl L, Ohrbach R, LeResche L, Truelove E. Reliability, validity, and clinical utility of the research diagnostic criteria for temporomandibular disorders Axis II scales: Depression, non-specific physical symptoms, and graded chronic pain. J Orofac Pain 2002;16:207–220.

27. Kotiranta U, Suvinen T, Forssell H. Tailored treatments in temporomandibular disorders: Where are we now? A systematic qualitative literature review. J Oral Facial Pain Headache 2014;28:28–37.

28. Kotiranta U, Suvinen T, Kauko T, et al. Subtyping patients with temporomandibular disorders in a primary health care setting on the basis of the research diagnostic criteria for temporomandibular disorders Axis II painrelated disability: A step toward tailored treatment planning? J Oral Facial Pain Headache 2015;29:126–134.

29. Schiffman E, Ohrbach R, Truelove E, et al. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for clinical and research applications: Recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Group. J Oral Facial Pain Headache 2014;28:6–27.

30. Ohrbach R, Bjorner J, Jezewski M, John MT, Lobbezoo F. Guidelines for Establishing Cultural Equivalency of Instruments. Updated 11 May 2013. https://buffalo.app.box. com/s/bl4g2beu64kgse4hniy9pghiy6ck5f45. Accessed 12 October 2021.

31. Ohrbach R (ed). Diagnostic Criteria for Temporomandibular Disorders: Assessment Instruments (Finnish). Version 15May2016. [Diagnostiset Kriteerit Purentaelimistön Kivuille ja Toimintahäiriöille (DC/TMD-FIN): Tutkimusinstrumentit]. Sipilä K, Suvinen T (translators). https://buffalo.app.box. com/s/633g52vu7c33f4j59fqwpgztjxhppms7. Accessed 12 October 2021.

32. Leskinen J, Suvinen T, Teerijoki-Oksa T, et al. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD): Interexaminer reliability of the Finnish version of Axis I clinical diagnoses. J Oral Rehabil 2017;44:493–499.

33. Suvinen T, Rantala M (translators). Purentaelimistön kivut ja toimintahäiriöt (TMD). Tieteelliset diagnostiset kriteerit. Version: 01Feb2010. https://ubwp.buffalo.edu/rdc-tmdinternational/tmd-assessmentdiagnosis/rdc-tmd/translations/Finnish/. Accessed 12 October 2021.

34. Ohrbach R, Knibbe W. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) Scoring Manual for Self-Report Instruments. Version: October 30, 2018.

35. Suvinen TI, Kemppainen P, Le Bell Y, Kauko T, Forssell H. Assessment of pain drawings and self-reported comorbid pains as part of the biopsychosocial profiling of temporomandibular disorder pain patients. J Oral Facial Pain Headache 2016;30:287–295.

36. Linton SJ, Boersma K. Early identification of patients at risk of developing a persistent back problem: The predictive validity of the Orebro Musculoskeletal Pain Questionnaire. Clin J Pain 2003;19:80–86.

37. Derogatis LR. Symptom Checklist 90-R: Administration, Scoring, & Procedures manual, ed 3. Minneapolis: National Computer Systems, 1994.

38. Rosenstiel AK, Keefe FJ. The use of coping strategies in chronic low back pain patients: Relationship to patient characteristics and current adjustment. Pain 1983;17:33–44.

39. Canales GT, Guarda-Nardini L, Rizzatti-Barbosa CM, Conti PCR, Manfredini D. Distribution of depression, somatization and painrelated impairment in patients with chronic temporomandibular disorders. J Appl Oral Sci 2019;27:e20180210.

40. Manfredini D, Marini M, Pavan C, Pavan L, Guarda-Nardini L. Psychosocial profiles of painful TMD patients. J Oral Rehabil 2009;36:193–198.

41. De La Torre Canales G, Câmara-Souza MB, Muñoz Lora VRM, et al. Prevalence of psychosocial impairment in temporomandibular disorder patients: A systematic review. J Oral Rehabil 2018;45:881–889.

42. Su N, Lobbezoo F, van Wijk A, van der Heijden GJ, Visscher CM. Associations of pain intensity and pain related disability with psychological and sociodemographic factors in patients with temporomandibular disorders: A cross-sectional study at a specialised dental clinic. J Oral Rehabil 2017;44:187–196.

43. Plesh O, Wolfe F, Lane N. The relationship between fibromyalgia and temporomandibular disorders: prevalence and symptom severity. J Rheumatol 1996;23:1948–1952.

44. Ayouni I, Chebbi R, Hela Z, Dhidah M. Comorbidity between fibromyalgia and temporomandibular disorders: A systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol 2019;128:33–42.

45. Forssell H, Kauko T, Kotiranta U, Suvinen T. Predictors for future clinically significant pain in patients with temporomandibular disorder: A prospective cohort study. Eur J Pain 2017;21:188–197.

46. Turk DC, Rudy TE. A dual-diagnostic approach assesses TMD patients. J Mass Dent Soc 1995;44:16–19.

47. Otis JD. Flor, H., & Turk, D.C. (2011) Chronic Pain: An Integrated Biobehavioral Approach. Seattle: IASP Press. Cog Behav Pract 2013;20:117–118.

48. Durham J, Shen J, Breckons M, et al. Healthcare cost and impact of persistent orofacial pain: The DEEP study cohort. J Dent Res 2016;95:1147–1154.

49. Forssell H, Kotiranta U, Kauko T, Suvinen T. Explanatory models of illness and treatment goals in temporomandibular disorder pain patients reporting different levels of pain-related disability. J Oral Facial Pain Headache 2016;30:14–20.

50. Turner JA, Mancl L, Aaron LA. Short- and long-term efficacy of brief cognitive-behavioral therapy for patients with chronic temporomandibular disorder pain: A randomized controlled trial. Pain 2006;121:181–194.

51. Fillingim RB, Ohrbach R, Greenspan JD, et al. Potential psychosocial risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study. J Pain 2011;12(suppl 11):T46–T60.

52. Von Korff M, DeBar LL, Krebs EE, Kerns RD, Deyo RA, Keefe FJ. Graded chronic pain scale revised: mild, bothersome, and highimpact chronic pain. Pain 2020;161:651–661.

53. Häggman-Henrikson B, Ekberg EC, Ettlin DA, et al. Mind the gap: A systematic review of implementation of screening for psychological comorbidity in dental and dental hygiene educa-tion. J Dent Educ 2018;82:1065–1076.

54. Sharma S, Breckons M, Brönnimann Lambelet B, et al. Challenges in the clinical implementation of a biopsychosocial model for assessment and management of orofacial pain. J Oral Rehabil 2020;47:87–100.